Doping in Youth Sport: A Comprehensive

Review of Prevalence, Motivations, and

Medico-Ethical Implications

Keywords: youth doping, adolescent athletes, performance-enhancing drugs (PEDs), anabolic-

androgenic steroids (AAS), anti-doping, sports ethics, WADA, public health, motivational climate,
supplement contamination.

Abstract The use of performance-enhancing drugs (PEDs) among young people is a significant and
growing public health concern, extending beyond elite athletics into recreational and non-
competitive settings. This review synthesizes current evidence to analyse the prevalence,
motivations, and profound medico-ethical implications of youth doping. The primary objectives are
to examine the scale of the issue, deconstruct the complex factors driving PED use, and explore
variations across demographic groups. Key findings reveal that young people are motivated by a dual
desire to enhance athletic performance and improve physical appearance, with body image disorders
like muscle dysmorphia playing a significant role. Motivational mindsets, particularly an "ego-
oriented" focus on outperforming others, correlate strongly with pro-doping attitudes. The review
identifies significant differences in prevalence based on gender, age, and geographic region, noting a
troubling trend of early initiation, with some children first using substances before their 10th
birthday. The health risks are severe and potentially irreversible, spanning cardiovascular, endocrine,
and musculoskeletal damage, alongside severe psychological effects like aggression, depression, and
addiction. Ethically, the anti-doping system faces a complex challenge in applying punitive measures
designed for autonomous adults to minors, who possess limited capacity for informed consent and
are vulnerable to coercion from their entourage. This review concludes that effective intervention
must move beyond simple deterrence toward a multi-pronged strategy emphasizing early education,
fostering healthier motivational climates, implementing stricter regulation of the supplement
industry, and developing anti-doping policies that prioritize the protection and rehabilitation of
young athletes.

1.0 Introduction

The use of performance-enhancing drugs (PEDs) in youth sports has emerged as a significant and
escalating public health concern. Far from being an issue confined to elite professionals, it is
estimated that over 3 million athletes in the United States have used PEDs, with a concerning portion
—over 250,000—being adolescents. This trend threatens not only the principles of fair play but also
the immediate and long-term health of a physically and psychologically vulnerable population. The
World Anti-Doping Agency (WADA) defines doping broadly as the occurrence of one or more anti-
doping rule violations, which range from the presence of a prohibited substance in an athlete's
sample to trafficking and administration. The primary purpose of this review is to synthesize the
existing evidence on the prevalence of doping among young athletes, with a specific focus on critical
variations across age, gender, and geographical region. Furthermore, this review will deconstruct the
primary motivations and psychological predictors that drive young people toward PED use, and it will
explore the profound health consequences associated with these substances and the complex ethical
dilemmas that arise when applying stringent anti-doping regulations to minors. To provide a
comprehensive overview of the youth doping landscape, this document will first examine the
psychological and social factors that motivate young athletes, then present data on prevalence and
demographics, detail the severe health risks, and analyse the intricate ethical and regulatory
challenges involved.

2.0 Motivations and Psychological Predictors of Youth Doping

To develop effective anti-doping strategies for young people, it is strategically vital to understand the
underlying motivations that lead them to use performance-enhancing substances. These decisions
are rarely made in a vacuum; rather, they are the product of a complex interplay of psychological
traits, social pressures, and environmental influences. Research has identified two fundamental
motives that drive PED use in young populations: the desire to enhance sport performance and the
need to improve physical appearance. While athletes are primarily motivated by gaining a
competitive edge, a significant portion of adolescent users are non-athletes driven by body image
concerns. This phenomenon is highlighted by the finding that over 80% of Anabolic-Androgenic
Steroid (AAS) users have never used them for competitive athletics. For many young men, this is
linked to a form of body dysmorphic disorder known as "muscle dysmorphia," a pathological
preoccupation with muscularity and a perceived lack of size.

An athlete's core "achievement goal orientation" is a powerful predictor of their attitude toward
doping. A study of Czech adolescent athletes identified two contrasting orientations. First, in "task
orientation," success is defined by self-referenced criteria, such as personal improvement and skill
mastery. This orientation is closely linked to intrinsic motivation—participating for the inherent
enjoyment of the sport—and is associated with more negative attitudes toward doping. Conversely,
in "ego orientation," success is defined by normative comparison, such as outperforming others and
demonstrating superiority. This mindset is linked to extrinsic motivation (e.g., rewards, status) and a
greater acceptance of cheating, which manifests as more positive and permissive attitudes toward
doping.

An athlete’s "entourage"—including coaches, parents, and peers—creates a powerful social-cognitive

environment that can either protect them from or expose them to doping. Research shows that
coaches and friends can be significant sources of pressure, with coaches often viewed as a primary
source of information on performance matters. A WADA-funded European study identified four key
social-cognitive factors that regulate an adolescent's decision to use PEDs: favorable attitudes (a
belief that doping is acceptable), social norms (the perception that significant others approve), low
self-regulatory efficacy (a lack of confidence to resist pressure), and moral disengagement (the use of
personal justifications to rationalize illicit behaviour).

The decision to use PEDs rarely occurs in isolation. Evidence consistently shows that adolescent PED
users are more likely to engage in other health-harming behaviours, such as the abuse of alcohol and
other illegal substances like cannabis or heroin. Furthermore, multiple studies have identified a
strong positive relationship between the use of legal nutritional supplements (e.g., creatine, protein
powders) and the intention to use, or actual use of, illegal PEDs. This suggests that the use of legal
supplements may act as a "gateway," normalizing the practice of using substances to manipulate
body composition and performance, thereby lowering the threshold for transitioning to banned
substances. This web of psychological drivers and social pressures establishes why adolescents are
vulnerable to doping. To understand where this vulnerability is most acute, it is necessary to quantify
the scale of the problem across key demographic groups.

3.0 Prevalence and Demographic Variations

While understanding motivations is crucial for prevention, quantifying the scale of youth doping
across different populations helps to reveal where risks are most concentrated and which groups are
most vulnerable. The prevalence of PED use is not uniform; it varies significantly based on factors
such as age, gender, geographical region, and competitive context. Generally, studies indicate that
PED use tends to increase with age throughout adolescence. For example, a four-year follow-up
study of French preadolescents found that substance use rose from 1.2% at the beginning of the
study to 3.0% four years later. Perhaps most alarmingly, evidence indicates a disturbingly early age of
onset. A study of high school students in Denver reported a mean starting age of just 14 years old.
Furthermore, a systematic review revealed that some children's first experience with AAS can occur
before their 10th birthday, underscoring the urgent need for anti-doping education to begin in junior
high school or even earlier.

The evidence consistently shows that doping is significantly more prevalent among young males than
females. This gap is likely driven by a combination of factors, including a greater emphasis on
muscularity in male body image ideals and higher participation rates in strength-based sports. Data
from U.S. studies illustrate this disparity: a survey of Denver high school students found a prevalence
of 4.0% for boys compared to 1.3% for girls, while data from the National Youth Risk Behaviour
Surveillance System showed that 4.4% of boys admitted to using steroids, more than double the
2.2% reported by girls.

Prevalence rates also differ dramatically by geographical region. A WADA-funded European report
using the Single Sample Count model revealed stark differences in estimated doping prevalence
among young team athletes, with Greece having the highest estimate at 29.38%, followed by Italy at
17.84%, and Germany at 3.35%. Findings regarding the link between sports participation and doping
are more complex and sometimes conflicting. Some studies report a higher incidence among
athletes, particularly in strength-focused sports like American football and wrestling. Conversely, a
German study in Thuringia found that non-athletes reported higher substance use than both
recreational and competitive athletes. This supports the idea that body image enhancement is a
powerful driver of PED use, independent of formal athletic competition. These significant variations
in prevalence underscore that doping is not a monolithic issue, and the consequences for those who
engage in it are severe, affecting the developing bodies and minds of adolescents in profound ways.

4.0 Health Consequences and Systemic Risks

The pursuit of a performance edge or an idealized physique through PEDs comes at a severe and
often irreversible cost to the developing bodies and minds of young people. Unlike mature adults,
adolescents are undergoing critical developmental processes that are easily disrupted by the
supraphysiological doses of hormones and other substances associated with doping. The use of AAS,
the most common class of PEDs, is associated with a wide range of serious medical complications
affecting multiple organ systems.
  Cardiovascular: Users face an increased risk of cardiomyopathy (disease of the heart
muscle), accelerated atherosclerosis (hardening of the arteries), high blood pressure, and a
heightened risk of heart attack and stroke, even at a young age.

 Endocrine & Reproductive: PEDs severely disrupt the natural hormonal axis. This can lead to
anabolic steroid withdrawal hypogonadism, infertility, testicular atrophy in males, and
gynecomastia (development of breast tissue). In females, irreversible virilization can occur,
causing symptoms like voice deepening and hirsutism (excessive hair growth).

 Musculoskeletal: While users seek muscle growth, AAS can paradoxically cause stunted
growth in adolescents by triggering premature closure of the epiphyseal plates in long bones.
There is also an increased rate of tendon ruptures, as muscle strength outpaces the
connective tissue's ability to adapt.

 Hepatic (Liver): Oral AAS, particularly 17-α alkylated androgens, are known to be toxic to the
liver and can cause tumours and other serious damage.

 Dermatological: Common side effects include severe cystic acne on the face and body, as
well as accelerated male pattern baldness.

The impact of PEDs extends beyond physical health, causing significant psychological and behavioural
disturbances. During use, individuals are at risk for extreme mood swings, aggression, and mania,
often referred to as "roid rage." The withdrawal period is equally dangerous, commonly associated
with severe depression, which can increase the risk of suicidal thoughts and behaviours. AAS can also
be addictive, and it is estimated that approximately 1 million men in the U.S. may have experienced
AAS dependence, characterized by continued use despite negative consequences.

Beyond the direct effects of the drugs, young users are exposed to risks related to their acquisition
and administration. The nutritional supplement market is poorly regulated, creating a high risk of
contamination with banned substances, as illustrated by the case of Olympic weightlifter Abby
Raymond, who tested positive for Ostarine from a tainted supplement. Users who inject PEDs are at
risk for skin abscesses and blood-borne diseases like HIV and Hepatitis C from unsafe practices such
as needle sharing. Additionally, to evade school-based drug testing, some adolescents may switch to
more dangerous and undetectable substances, such as inhalants, which carry risks of permanent
brain damage and sudden death. These severe health consequences transform the issue of youth
doping from a matter of unfair competition into a critical public health crisis, posing profound ethical
challenges for the regulatory bodies tasked with managing it.

5.0 The Ethical and Regulatory Landscape

The issue of doping in youth sport transcends simple rule-breaking and enters a domain of profound
ethical complexity, forcing a confrontation between the mandate for fair play and the moral
imperative to protect a vulnerable population. The debate centres on fundamental questions of
responsibility, autonomy, and justice. A core philosophical conflict exists between anti-doping rules
and the limited autonomy of minors. True autonomous consent requires a capacity for critical self-
reflection—an ability to weigh long-term consequences against short-term desires and to resist
external pressures—which young athletes have not fully developed, particularly when influenced by
a powerful entourage. In recognition of this, WADA has established the "Protected Person" category
for athletes under 16 (or under 18 in some contexts). While this status acknowledges their
diminished culpability, it does not exempt them from sanctions. The case of 15-year-old figure skater
Kamila Valieva at the 2022 Winter Olympics powerfully illustrates this dilemma; her positive test
raised immediate questions about the role of her coaches and the surrounding sport system,
highlighting the injustice of placing the full burden of responsibility on a minor.

The debate over regulation often includes school-based drug testing. However, the American
Academy of Paediatrics has concluded that scientific evidence does not support the expansion of
these programs due to high costs, potential for inaccuracies, and the risk of unintended
consequences, such as driving students toward more dangerous substances. Furthermore, the
punitive nature of the anti-doping system raises questions of justice. The principle of strict liability,
where an athlete is responsible for any substance found in their body regardless of intent, is
particularly harsh for young athletes. Historical cases, such as those of 16-year-old gymnast Andreea
Răducan and 16-year-old swimmer Rick DeMont, who were stripped of Olympic medals due to
substances administered by team physicians, underscore the argument that applying the same
consequences to minors as to adults can be fundamentally unjust. The deep ethical complexities
inherent in youth doping reveal a tension between enforcing fair play and protecting vulnerable
athletes, necessitating a more nuanced approach beyond a purely punitive framework.

6.0 Discussion

This review synthesizes evidence demonstrating that youth doping is a multifaceted public health
issue, deeply rooted in a combination of psychological pressures, social dynamics, and specific
motivational orientations. The decision by a young person to use performance-enhancing substances
is not a simple choice but the outcome of a complex interplay between the individual's mindset and
the environment they inhabit.

The conflicting data on prevalence—where some studies show higher use among competitive
athletes while others find greater prevalence in non-athletes—is a critical finding. It suggests that
motivations related to body image and appearance are at least as powerful, if not more so in some
populations, than motivations purely related to sport performance. This dual-motive reality
complicates prevention efforts, indicating that anti-doping messages focused solely on "the spirit of
sport" will fail to reach a large segment of young users whose goals are aesthetic rather than athletic.

The analysis also highlights the critical role of the adult-led ecosystem surrounding the young
athlete. The influence of the "entourage"—coaches, parents, and peers—can create a climate that
either fosters resilience or normalizes risky behaviour. This is compounded by an unregulated
nutritional supplement industry that exposes young consumers to contaminated products and acts
as a potential gateway to more dangerous substances. When this occurs within a broader sports
culture that often prioritizes winning over well-being, the adolescent—who is uniquely vulnerable
both physically during development and psychologically due to a nascent capacity for critical self-
reflection—is placed at magnified risk. The harm is therefore not solely a product of the substance
itself, but of the systemic pressures that make its use seem like a viable, or even necessary, option.

7.0 Conclusion

This review confirms that the use of performance-enhancing drugs by young people is a prevalent
and dangerous issue, driven by powerful motivations related to both performance and appearance,
and resulting in severe, potentially irreversible health consequences. The complexity of the problem
demands a sophisticated and holistic response that moves beyond simple deterrence and punitive
sanctions.

Based on the evidence presented, an effective path forward must be built on a multi-pronged
strategy that addresses the issue at its roots. This approach must include:

 Early and Continuous Education: Prevention programs must begin in junior high school, or
even sooner, to shape values and attitudes before risky behaviors become entrenched.

 Fostering a Healthy Motivational Climate: Interventions should be designed to promote a

"task-oriented" mindset that values personal growth, skill development, and health over a
purely "ego-oriented" focus on winning at all costs.

 Stricter Industry Regulation: There is an urgent need for greater governmental regulation
and oversight of the nutritional supplement industry to prevent product contamination and
protect young consumers.

 Re-evaluation of Anti-Doping Policy: The anti-doping system must evolve to better

distinguish between autonomous adults and vulnerable minors. For "Protected Persons,"
policies should prioritize education, protection, and rehabilitation over purely punitive
measures, holding the surrounding adult entourage accountable.

Ultimately, the challenge of youth doping is not one that can be solved by anti-doping organizations
alone. It is a shared responsibility. The entire sports community—including coaches, parents,
educators, healthcare providers, and policymakers—has a collective moral obligation to create an
environment that protects the health, well-being, and ethical development of its youngest and most
vulnerable participants.

8.0 References

Barkoukis, V., Lazuras, L., Lucidi, F., & Tsorbatzoudis, H. (2015). Nutritional supplement and doping
use in sport: possible underlying social cognitive processes. Scandinavian Journal of Medicine &
Science in Sports, 25(6), e582–e588. [Link]

Dandoy, C., & Gereige, R. S. (2012). Performance-enhancing drugs. Pediatrics in Review, 33(6), 265–
272. [Link]

Goldman, A. L., Pope, H. G., Jr., & Bhasin, S. (2019). The health threat posed by the hidden epidemic
of anabolic steroid use and body image disorders among young men. The Journal of Clinical
Endocrinology & Metabolism, 104(4), 1069–1074. [Link]

Levy, S., Schizer, M., & Committee on Substance Abuse. (2015). Adolescent drug testing policies in
schools. Pediatrics, 135(4), e1107–e1112. [Link]

Lucidi, F., Zelli, A., Mallia, L., Grano, C., & Brand, R. (2014). A European analysis of young team
athletes’ beliefs about doping and appraisals of others encouraging substance use. Final Report to
the World Anti-Doping Agency. Sapienza University of Rome.

Mudrak, J., Slepicka, P., & Slepickova, I. (2018). Sport motivation and doping in adolescent athletes.
PLOS ONE, 13(10), e0205222. [Link]
Nicholls, A. R., Cope, E., Bailey, R., Koenen, K., Dumon, D., Theodorou, N. C., Chanal, B., Saint Laurent,
D., Müller, D., Andrés, M. P., Kristensen, A. H., Thompson, M. A., Baumann, W., & Laurent, J.-F. (2017).
Children's first experience of taking anabolic-androgenic steroids can occur before their 10th
birthday: A systematic review identifying 9 factors that predicted doping among young people.
Frontiers in Psychology, 8, 1015. [Link]

Rathee, S. (2023). The impact of performance-enhancing drugs on young athletes. International

Journal of Applied Research, 9(9), 07-09. [Link]

Tanner, S. M., Miller, D. W., & Alongi, C. (1995). Anabolic steroid use by adolescents: Prevalence,
motives, and knowledge of risks. Clinical Journal of Sport Medicine, 5(2), 108–115.
[Link]

Teetzel, S. (2022). Philosophical perspectives on doping sanctions and young athletes. Frontiers in
Sports and Active Living, 4, 841033. [Link]

Tobin, J. (2024, June 23). Protecting young athletes from doping in sports. Sports Pharmacy Network.
[Link]

Wanjek, B., Rosendahl, J., Strauss, B., & Gabriel, H. H. (2007). Doping, drugs and drug abuse among
adolescents in the State of Thuringia (Germany): Prevalence, knowledge and attitudes. International
Journal of Sports Medicine, 28(4), 346–353. [Link]